Table 3

Khorana et al risk score for chemotherapy-related VTE risk prediction in patients with cancer31

Patient characteristicScore
Site of cancer
 Very high risk
 (stomach, pancreas)
 High risk
 (lung, lymphoma, gynaecological, genitourinary excluding prostate)
Prechemotherapy platelet count ≥350×109/L1
Prechemotherapy leucocyte count ≥11×109/L1
Haemoglobin <10 g/dL or use of erythropoiesis-stimulating agents1
BMI ≥35 kg/m21
  • BMI, body mass index; VTE, venous thromboembolism.